Clinical Trial Update: The Efficacy of Sequential Therapy as Second Line Therapy for Refractory Helicobacter Pylori Infection - A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluating sequential therapy as a second-line treatment for patients with refractory Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: H. Pylori Infection | Phase 4 | Status: COMPLETED